{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T19:21:37Z","timestamp":1790018497946,"version":"4.0.1"},"reference-count":83,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006260","name":"Rheumatology Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006260","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Rheumatology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.berh.2025.102108","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T16:00:02Z","timestamp":1763568002000},"page":"102108","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["IgG4-Related disease: From diagnosis to remission"],"prefix":"10.1016","volume":"39","author":[{"given":"Arjun","family":"Mahajan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Tinianow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.berh.2025.102108_bib1","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1056\/NEJM200103083441005","article-title":"High serum IgG4 concentrations in patients with sclerosing pancreatitis","volume":"344","author":"Hamano","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.berh.2025.102108_bib2","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1007\/s00535-003-1175-y","article-title":"A new clinicopathological entity of IgG4-related autoimmune disease","volume":"38","author":"Kamisawa","year":"2003","journal-title":"J Gastroenterol"},{"issue":"1","key":"10.1016\/j.berh.2025.102108_bib3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.anl.2011.01.023","article-title":"A novel concept of Mikulicz's disease as IgG4-related disease","volume":"39","author":"Himi","year":"2012","journal-title":"Auris Nasus Larynx"},{"issue":"10","key":"10.1016\/j.berh.2025.102108_bib4","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s00535-022-01891-7","article-title":"Current status of type 1 (IgG4-related) autoimmune pancreatitis","volume":"57","author":"Uchida","year":"2022","journal-title":"J Gastroenterol"},{"issue":"1","key":"10.1016\/j.berh.2025.102108_bib5","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/annrheumdis-2013-204907","article-title":"The diagnostic utility of serum IgG4 concentrations in IgG4-related disease","volume":"74","author":"Carruthers","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.berh.2025.102108_bib6","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1146\/annurev-med-050219-034449","article-title":"Clinical perspectives on IgG4-related disease and its classification","volume":"73","author":"Katz","year":"2022","journal-title":"Annu Rev Med"},{"issue":"7","key":"10.1016\/j.berh.2025.102108_bib7","doi-asserted-by":"crossref","first-page":"e481","DOI":"10.1016\/S2665-9913(24)00022-5","article-title":"Proliferative features of IgG4-related disease","volume":"6","author":"Katz","year":"2024","journal-title":"Lancet Rheumatol"},{"issue":"7","key":"10.1016\/j.berh.2025.102108_bib8","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1136\/ard-2023-223950","article-title":"Incidence, prevalence and mortality of IgG4-related disease in the USA: a claims-based analysis of commercially insured adults","volume":"82","author":"Wallace","year":"2023","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.berh.2025.102108_bib9","article-title":"Current and future advances in practice: IgG4-Related disease","volume":"8","author":"Wallace","year":"2024","journal-title":"Rheumatol Adv Pract"},{"key":"10.1016\/j.berh.2025.102108_bib10","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1007\/s00535-019-01658-7","article-title":"Nationwide epidemiological survey of autoimmune pancreatitis in Japan in 2016","volume":"55","author":"Masamune","year":"2020","journal-title":"J Gastroenterol"},{"issue":"1","key":"10.1016\/j.berh.2025.102108_bib11","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/1744666X.2023.2274358","article-title":"Pediatric IgG4-related disease: a descriptive review","volume":"20","author":"Hara","year":"2024","journal-title":"Expet Rev Clin Immunol"},{"issue":"6","key":"10.1016\/j.berh.2025.102108_bib12","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1093\/rheumatology\/keaa651","article-title":"Differences in clinical characteristics of IgG4-related disease across age groups: a prospective study of 737 patients","volume":"60","author":"Lu","year":"2021","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.berh.2025.102108_bib13","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1016\/S2665-9913(19)30017-7","article-title":"Management of IgG4-related disease","volume":"1","author":"Zhang","year":"2019","journal-title":"Lancet Rheumatol"},{"issue":"7","key":"10.1016\/j.berh.2025.102108_bib14","doi-asserted-by":"crossref","first-page":"e460","DOI":"10.1016\/S2665-9913(24)00089-4","article-title":"Sex as a predictor of clinical phenotype and determinant of immune response in IgG4-related disease: a retrospective study of patients fulfilling the American college of rheumatology\u2013european league against rheumatism classification criteria","volume":"6","author":"Jha","year":"2024","journal-title":"Lancet Rheumatol"},{"issue":"3","key":"10.1016\/j.berh.2025.102108_bib15","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1136\/annrheumdis-2018-214603","article-title":"Clinical phenotypes of IgG4-related disease: an analysis of two international cross-sectional cohorts","volume":"78","author":"Wallace","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.berh.2025.102108_bib16","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.jaci.2015.12.1330","article-title":"Clonal expansion of CD4+ cytotoxic T lymphocytes in patients with IgG4-related disease","volume":"138","author":"Mattoo","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.berh.2025.102108_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13075-017-1231-2","article-title":"Circulating plasmablasts\/plasma cells: a potential biomarker for IgG4-related disease","volume":"19","author":"Lin","year":"2017","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.berh.2025.102108_bib18","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/25785826.2024.2407224","article-title":"The immunological pathogenesis of IgG4-related disease categorized by clinical characteristics","volume":"48","author":"Akiyama","year":"2025","journal-title":"Immunol Med"},{"issue":"Suppl 112","key":"10.1016\/j.berh.2025.102108_bib19","first-page":"186","article-title":"Risk factors of relapse following glucocorticoid tapering in IgG4-related disease","volume":"36","author":"Sasaki","year":"2018","journal-title":"Clin Exp Rheumatol"},{"issue":"8","key":"10.1016\/j.berh.2025.102108_bib20","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1136\/gutjnl-2015-310336","article-title":"Pathogenicity of IgG in patients with IgG4-related disease","volume":"65","author":"Shiokawa","year":"2016","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.berh.2025.102108_bib21","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s10067-022-06413-7","article-title":"Roles of IgG4 and IgG4\/IgG ratio to IgG4-related disease in patients with elevated serum IgG4 level","volume":"42","author":"Wang","year":"2023","journal-title":"Clin Rheumatol"},{"issue":"3","key":"10.1016\/j.berh.2025.102108_bib22","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.jaci.2014.03.034","article-title":"De novo oligoclonal expansions of circulating plasmablasts in active and relapsing IgG4-related disease","volume":"134","author":"Mattoo","year":"2014","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.berh.2025.102108_bib23","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1136\/annrheumdis-2019-216561","article-title":"The 2019 American college of rheumatology\/european league against rheumatism classification criteria for IgG4-related disease","volume":"79","author":"Wallace","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2025.102108_bib24","series-title":"Seminars in diagnostic pathology","first-page":"61","article-title":"Lymphadenopathy associated with IgG4-related disease: diagnosis & differential diagnosis","author":"Wick","year":"2018"},{"issue":"8","key":"10.1016\/j.berh.2025.102108_bib25","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.crad.2023.03.003","article-title":"Imaging manifestations of IgG4-related disease","volume":"78","author":"Naik","year":"2023","journal-title":"Clin Radiol"},{"issue":"1","key":"10.1016\/j.berh.2025.102108_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.lpm.2020.104014","article-title":"Pathological characteristics and diagnosis of IgG4-related disease","volume":"49","author":"Zen","year":"2020","journal-title":"Presse Med"},{"issue":"9","key":"10.1016\/j.berh.2025.102108_bib27","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/modpathol.2012.72","article-title":"Consensus statement on the pathology of IgG4-related disease","volume":"25","author":"Deshpande","year":"2012","journal-title":"Mod Pathol [Internet]"},{"key":"10.1016\/j.berh.2025.102108_bib28","series-title":"Seminars in diagnostic pathology","first-page":"191","article-title":"The pathology of IgG4-related disease: critical issues and challenges","author":"Deshpande","year":"2012"},{"issue":"1","key":"10.1016\/j.berh.2025.102108_bib29","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1136\/annrheumdis-2014-205233","article-title":"Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations","volume":"74","author":"Wallace","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.berh.2025.102108_bib30","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1002\/art.39205","article-title":"IgG4\u2010related disease: clinical and laboratory features in one hundred twenty\u2010five patients","volume":"67","author":"Wallace","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.berh.2025.102108_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1020459","article-title":"Correlation between serologic parameters and disease activity of IgG4-related disease: differences between patients with normal and elevated serum IgG4 concentrations","volume":"13","author":"Kwon","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.berh.2025.102108_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.787422","article-title":"The role of IgG4 in autoimmunity and rheumatic diseases","volume":"12","author":"Maslinska","year":"2022","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.berh.2025.102108_bib33","first-page":"408","article-title":"The positive predictive value of a very high serum IgG4 concentration for the diagnosis of IgG4-Related disease","volume":"50","author":"Baker","year":"2022","journal-title":"J Rheumatolc"},{"issue":"3","key":"10.1016\/j.berh.2025.102108_bib34","first-page":"408","article-title":"The positive predictive value of a very high serum IgG4 concentration for the diagnosis of IgG4-Related disease","volume":"50","author":"Baker","year":"2022","journal-title":"J Rheumatolc"},{"issue":"7","key":"10.1016\/j.berh.2025.102108_bib35","doi-asserted-by":"crossref","first-page":"e469","DOI":"10.1016\/S2665-9913(23)00299-0","article-title":"Fibrotic phenotype of IgG4-related disease","volume":"6","author":"Lanzillotta","year":"2024","journal-title":"Lancet Rheumatol"},{"issue":"1","key":"10.1016\/j.berh.2025.102108_bib36","article-title":"Salivary gland pathology in IgG4\u2010related disease: a comprehensive review","volume":"2018","author":"Puxeddu","year":"2018","journal-title":"J Immunol Res"},{"issue":"8","key":"10.1016\/j.berh.2025.102108_bib37","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1136\/ard.2008.089169","article-title":"Proposal for a new clinical entity, IgG4-positive multiorgan lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders","volume":"68","author":"Masaki","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.berh.2025.102108_bib38","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s10384-021-00847-3","article-title":"Clinical features and symptoms of IgG4-related ophthalmic disease: a multicenter study","volume":"65","author":"Goto","year":"2021","journal-title":"Jpn J Ophthalmol"},{"issue":"6","key":"10.1016\/j.berh.2025.102108_bib39","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1159\/000525955","article-title":"Novel advances in the study of IgG4-related disease in the eye and ocular adnexa","volume":"65","author":"Zhang","year":"2022","journal-title":"Ophthalmic Res"},{"issue":"4","key":"10.1016\/j.berh.2025.102108_bib40","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s10384-024-01072-4","article-title":"The 2023 revised diagnostic criteria for IgG4-related ophthalmic disease","volume":"68","author":"Takahira","year":"2024","journal-title":"Jpn J Ophthalmol"},{"issue":"3","key":"10.1016\/j.berh.2025.102108_bib41","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1136\/flgastro-2018-101001","article-title":"Diagnosis and management of IgG4-related disease","volume":"10","author":"Hegade","year":"2019","journal-title":"Frontline Gastroenterol"},{"key":"10.1016\/j.berh.2025.102108_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2025.152742","article-title":"Defining pancreatic damage and symptom burden in IgG4-related autoimmune pancreatitis: a cross-sectional study of 118 patients from a single-center registry","volume":"73","author":"Katz","year":"2025","journal-title":"Semin Arthritis Rheum"},{"issue":"41","key":"10.1016\/j.berh.2025.102108_bib43","doi-asserted-by":"crossref","DOI":"10.3748\/wjg.v20.i41.15177","article-title":"Autoimmune pancreatitis in the context of IgG4-related disease: review of imaging findings","volume":"20","author":"Lee","year":"2014","journal-title":"World J Gastroenterol: WJG"},{"issue":"10","key":"10.1016\/j.berh.2025.102108_bib44","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1038\/s41395-018-0184-7","article-title":"Current concept of autoimmune pancreatitis and IgG4-related disease","volume":"113","author":"Okazaki","year":"2018","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.berh.2025.102108_bib45","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/jhbp.596","article-title":"Clinical practice guidelines for IgG4\u2010related sclerosing cholangitis","volume":"26","author":"Kamisawa","year":"2019","journal-title":"J Hepatobiliary Pancreat Sci"},{"issue":"6","key":"10.1016\/j.berh.2025.102108_bib46","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.2214\/AJR.19.21519","article-title":"IgG4-related sclerosing cholangitis: a clinical and imaging review","volume":"213","author":"Madhusudhan","year":"2019","journal-title":"Am J Roentgenol"},{"issue":"2","key":"10.1016\/j.berh.2025.102108_bib47","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/rheumatology\/keaa411","article-title":"Clinical features of IgG4-related retroperitoneal fibrosis among 407 patients with IgG4-related disease: a retrospective study","volume":"60","author":"Liu","year":"2021","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2025.102108_bib48","series-title":"Seminars in arthritis and rheumatism","article-title":"IgG4-related disease as a variable-vessel vasculitis: a case series of 13 patients with medium-sized coronary artery involvement","author":"Katz","year":"2023"},{"issue":"28","key":"10.1016\/j.berh.2025.102108_bib49","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000003344","article-title":"Large vessel involvement by IgG4-related disease","volume":"95","author":"Perugino","year":"2016","journal-title":"Medicine"},{"issue":"1","key":"10.1016\/j.berh.2025.102108_bib50","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3400\/avd.ra.18-00012","article-title":"IgG4-related arterial disease","volume":"11","author":"Kasashima","year":"2018","journal-title":"Ann Vasc Dis"},{"issue":"15","key":"10.1016\/j.berh.2025.102108_bib51","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000000680","article-title":"IgG4-related disease: dataset of 235 consecutive patients","volume":"94","author":"Inoue","year":"2015","journal-title":"Medicine"},{"issue":"2","key":"10.1016\/j.berh.2025.102108_bib52","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1080\/14397595.2018.1548089","article-title":"IgG4-related respiratory disease","volume":"29","author":"Matsui","year":"2019","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.berh.2025.102108_bib53","series-title":"Pulmonary manifestations of IgG4-Related disease [Internet]","author":"Katz","year":"2025"},{"issue":"1","key":"10.1016\/j.berh.2025.102108_bib54","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1148\/radiol.2511080965","article-title":"Immunoglobulin G4\u2013related lung disease: CT findings with pathologic correlations","volume":"251","author":"Inoue","year":"2009","journal-title":"Radiology"},{"issue":"162","key":"10.1016\/j.berh.2025.102108_bib55","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0078-2021","article-title":"Thoracic involvement and imaging patterns in IgG4-related disease","volume":"30","author":"Muller","year":"2021","journal-title":"Eur Respir Rev"},{"issue":"1","key":"10.1016\/j.berh.2025.102108_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.lpm.2020.104017","article-title":"Renal involvement in IgG4-related disease","volume":"49","author":"Boffa","year":"2020","journal-title":"Presse Med"},{"issue":"5","key":"10.1016\/j.berh.2025.102108_bib57","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.4103\/jcrt.JCRT_697_20","article-title":"Renal pseudotumor: a new challenge in the diagnosis of immunoglobulin G4-related disease","volume":"16","author":"Wu","year":"2020","journal-title":"J Cancer Res Therapeut"},{"issue":"4","key":"10.1016\/j.berh.2025.102108_bib58","doi-asserted-by":"crossref","DOI":"10.1097\/MPA.0000000000000325","article-title":"Nationwide epidemiological survey of autoimmune pancreatitis in Japan in 2011","volume":"44","author":"Kanno","year":"2015","journal-title":"Pancreas"},{"issue":"11","key":"10.1016\/j.berh.2025.102108_bib59","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1136\/gutjnl-2012-302886","article-title":"Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo clinic experience","volume":"62","author":"Hart","year":"2013","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.berh.2025.102108_bib60","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1080\/14397595.2016.1259602","article-title":"A multicenter phase II prospective clinical trial of glucocorticoid for patients with untreated IgG4-related disease","volume":"27","author":"Masaki","year":"2017","journal-title":"Mod Rheumatol"},{"issue":"1","key":"10.1016\/j.berh.2025.102108_bib61","doi-asserted-by":"crossref","first-page":"6195","DOI":"10.1038\/s41598-017-06520-5","article-title":"Efficacy of cyclophosphamide treatment for immunoglobulin G4-related disease with addition of glucocorticoids","volume":"7","author":"Yunyun","year":"2017","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.berh.2025.102108_bib62","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1093\/rheumatology\/key227","article-title":"Efficacy and safety of low dose mycophenolate mofetil treatment for immunoglobulin G4-related disease: a randomized clinical trial","volume":"58","author":"Yunyun","year":"2019","journal-title":"Rheumatology"},{"issue":"6","key":"10.1016\/j.berh.2025.102108_bib63","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/j.semarthrit.2020.01.010","article-title":"Additive effect of leflunomide and glucocorticoids compared with glucocorticoids monotherapy in preventing relapse of IgG4-related disease: a randomized clinical trial","volume":"50","author":"Wang","year":"2020","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.berh.2025.102108_bib64","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1093\/rheumatology\/kez380","article-title":"Glucocorticoids and steroid sparing medications monotherapies or in combination for IgG4-RD: a systematic review and network meta-analysis","volume":"59","author":"Omar","year":"2020","journal-title":"Rheumatology"},{"issue":"6","key":"10.1016\/j.berh.2025.102108_bib65","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.cgh.2018.09.051","article-title":"Risk factors for rate of relapse and effects of steroid maintenance therapy in patients with autoimmune pancreatitis: systematic review and meta-analysis","volume":"17","author":"Tacelli","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.berh.2025.102108_bib66","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1136\/gutjnl-2016-312049","article-title":"Randomised controlled trial of long-term maintenance corticosteroid therapy in patients with autoimmune pancreatitis","volume":"66","author":"Masamune","year":"2017","journal-title":"Gut"},{"issue":"12","key":"10.1016\/j.berh.2025.102108_bib67","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1056\/NEJMoa2409712","article-title":"Inebilizumab for treatment of IgG4-Related disease","volume":"392","author":"Stone","year":"2025","journal-title":"New England J Med"},{"issue":"11","key":"10.1016\/j.berh.2025.102108_bib68","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1136\/gutjnl-2012-302886","article-title":"Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo clinic experience","volume":"62","author":"Hart","year":"2013","journal-title":"Gut"},{"issue":"7","key":"10.1016\/j.berh.2025.102108_bib69","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.pan.2021.06.009","article-title":"Efficacy and safety of rituximab for IgG4-related pancreato-biliary disease: a systematic review and meta-analysis","volume":"21","author":"Lanzillotta","year":"2021","journal-title":"Pancreatology"},{"issue":"9","key":"10.1016\/j.berh.2025.102108_bib70","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0183844","article-title":"Long-term efficacy and safety of rituximab in IgG4-related disease: data from a French nationwide study of thirty-three patients","volume":"12","author":"Ebbo","year":"2017","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.berh.2025.102108_bib71","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2014-206605","article-title":"Rituximab for IgG4-related disease: a prospective, open-label trial","volume":"74","author":"Carruthers","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2025.102108_bib72","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ejim.2019.12.029","article-title":"Long-term efficacy of maintenance therapy with rituximab for IgG4-related disease","volume":"74","author":"Campochiaro","year":"2020","journal-title":"Eur J Intern Med"},{"issue":"12","key":"10.1016\/j.berh.2025.102108_bib73","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1016\/j.cgh.2018.02.049","article-title":"Rituximab maintenance therapy reduces rate of relapse of pancreaticobiliary immunoglobulin G4-related disease","volume":"16","author":"Majumder","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.berh.2025.102108_bib74","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1136\/ard-2023-224487","article-title":"Withdrawal of immunosuppressants and low-dose steroids in patients with stable IgG4-RD (WInS IgG4-RD): an investigator-initiated, multicentre, open-label, randomised controlled trial","volume":"83","author":"Peng","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2025.102108_bib75","doi-asserted-by":"crossref","DOI":"10.1097\/EDE.0000000000001422","article-title":"Risk of serious infection with low-dose glucocorticoids in patients with rheumatoid arthritis: an instrumental variable analysis","volume":"33","author":"George","year":"2022","journal-title":"Epidemiology"},{"key":"10.1016\/j.berh.2025.102108_bib76","article-title":"Thalidomide can effectively prevent relapse in IgG4-related disease outweighing its side effects: a multicentre, randomised, double-blinded, placebo-controlled study","author":"Chen","year":"2025","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2025.102108_bib77","doi-asserted-by":"crossref","first-page":"e442","DOI":"10.1016\/S2665-9913(23)00157-1","article-title":"Evaluation of the safety, efficacy, and mechanism of action of obexelimab for the treatment of patients with IgG4-related disease: an open-label, single-arm, single centre, phase 2 pilot trial","volume":"5","author":"Perugino","year":"2023","journal-title":"Lancet Rheumatol"},{"issue":"2","key":"10.1016\/j.berh.2025.102108_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/S2665-9913(21)00359-3","article-title":"Abatacept in igg4-related disease: a prospective, open-label, single-arm, single-centre, proof-of-concept study","volume":"4","author":"Matza","year":"2022","journal-title":"The Lancet Rheumatology"},{"issue":"Suppl 9","key":"10.1016\/j.berh.2025.102108_bib79","article-title":"Treatment of IgG4-related disease (IgG4-RD) with elotuzumab, an inhibitor of SLAM-F7: report of a phase 2 clinical trial [abstract]","volume":"76","author":"Stone","year":"2024","journal-title":"Arthritis Rheumatol"},{"issue":"8","key":"10.1016\/j.berh.2025.102108_bib80","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1111\/1756-185X.13633","article-title":"Efficacy and safety of iguratimod plus corticosteroid as bridge therapy in treating mild IgG4-related diseases: a prospective clinical trial","volume":"22","author":"Zhang","year":"2019","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.berh.2025.102108_bib81","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1111\/1756-185X.13194","article-title":"Clinical characteristics and outcomes of 61 patients with chronic periaortitis including IgG4-related and non-IgG4-related cases","volume":"20","author":"Kim","year":"2017","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.berh.2025.102108_bib82","doi-asserted-by":"crossref","first-page":"e111","DOI":"10.1016\/j.athoracsur.2013.11.074","article-title":"Surgical procedure in immunoglobulin G4-Related ascending aortitis?","volume":"97","author":"Colombier","year":"2014","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.berh.2025.102108_bib83","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.124.004672","article-title":"Thoracic aortic disease in patients with heterozygous variants outside the central region of FBN2","author":"Demal","year":"2025","journal-title":"Circ Genom Precis Med"}],"container-title":["Best Practice & Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694225000762?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694225000762?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T08:35:45Z","timestamp":1773822945000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694225000762"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":83,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S1521694225000762"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2025.102108","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IgG4-Related disease: From diagnosis to remission","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Rheumatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.berh.2025.102108","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102108"}}